respiratori
infect
complic
pregnanc
encount
frequent
encompass
broad
rang
disord
although
respiratori
infect
usual
seen
commonli
pregnanc
often
result
greater
morbid
mortal
secondari
physiolog
adapt
occur
pregnanc
pregnant
patient
one
disord
requir
higher
level
surveil
intervent
pulmonari
physiolog
chang
pregnanc
discuss
detail
elsewher
issu
mani
organ
system
respiratori
system
undergo
sever
adapt
pregnanc
tidal
volum
increas
although
respiratori
rate
remain
unchang
result
increas
minut
ventil
higher
nonpregn
women
minut
oxygen
uptak
also
increas
allow
increas
oxygen
requir
pregnanc
advanc
chang
forc
vital
capac
lung
complianc
diffus
capac
howev
function
residu
capac
decreas
term
total
pulmonari
resist
also
decreas
pregnanc
possibl
increas
progesteron
level
although
overal
hemoglobin
amount
increas
allow
increas
total
oxygencarri
capac
increas
blood
volumewhich
disproportion
increas
hemoglobin
concentrationresult
physiolog
anemia
see
front
matter
decreas
arteri
oxygen
content
small
amount
third
trimest
final
diaphragm
elev
much
cm
pregnanc
transvers
chest
diamet
increas
cm
acut
bacteri
sinus
infect
mucosa
paranas
sinus
nasal
caviti
develop
commonli
complic
viral
upper
respiratori
infect
one
common
diseas
outpati
clinic
set
annual
cost
billion
unit
state
acut
viral
sinus
common
usual
resolv
without
treatment
howev
bacteri
sinus
complic
viral
sinus
case
requir
antimicrobi
therapi
prevent
complic
distinguish
viral
bacteri
sinus
difficult
sinus
develop
inflammatori
edema
sinu
mucosa
obstruct
sinu
ostia
decreas
mucociliari
activ
stasi
provid
milieu
conduc
bacteri
growth
common
bacteri
pathogen
associ
acut
bacteri
sinus
includ
streptococcu
pneumonia
h
influenza
streptococcu
pyogen
neisseria
speci
moraxella
catarrhali
common
children
staphylococcu
aureu
anaerob
bacteria
fungal
sinus
primarili
aspergillosi
also
consid
particularli
women
histori
immunoincompet
risk
factor
develop
acut
bacteri
sinus
includ
histori
allerg
disord
dental
infect
anatom
abnorm
deviat
septum
nasal
polyp
cleft
palat
nasogastr
nasotrach
intub
barotrauma
chemic
irrit
cystic
fibrosi
immunodefici
although
one
older
studi
suggest
increas
incid
sinus
pregnanc
recent
data
avail
address
issu
acut
viral
bacteri
sinus
often
present
nasal
congest
purul
nasal
postnas
discharg
sinu
pain
pressur
affect
sinu
cough
sinu
headach
fever
malais
distinguish
bacteri
viral
sinusitisa
challeng
yet
import
distinct
manag
variesa
person
must
persist
symptom
longer
day
common
find
bacteri
infect
develop
set
viral
sinus
report
two
phase
improv
betweena
doubl
sicken
sign
chang
color
nasal
discharg
clearyellow
greenish
also
indic
progress
bacteri
sinus
transillumin
sinus
plain
radiograph
sinus
may
help
confirm
sinus
distinguish
viral
bacteri
sinus
ct
mri
reserv
evalu
complic
sinu
case
although
uncommon
complic
acut
bacteri
sinus
sever
local
extens
infect
sinu
bone
orbit
intracrani
caviti
occur
central
nervou
system
involv
ie
mening
brain
abscess
cavern
sinu
infect
appropri
antimicrobi
therapi
decreas
incid
complic
markedli
last
decad
diagnosi
acut
bacteri
sinus
made
antimicrobi
therapi
system
relief
initi
analges
antipyret
decongest
moistur
techniqu
includ
nasal
irrig
steam
inhal
warm
pack
use
provid
relief
recommend
antimicrobi
therapi
erad
bacteri
pathogen
vari
among
countri
depend
common
pathogen
pattern
antimicrobi
resist
unit
state
american
academi
otolaryngologyhead
neck
surgeri
guidelin
first
line
treatment
regimen
includ
amoxicillin
amoxicillinclavulan
acid
secondthirdgener
cephalosporin
accept
regimen
pregnanc
given
day
penicillinallerg
patient
cours
one
macrolid
particularli
azithromycin
warrant
macrolid
resist
becom
major
problem
mani
european
countri
recommend
area
surveil
unit
state
show
lower
rate
resist
macrolid
remain
altern
firstlin
therapi
patient
penicillin
allergi
penicillinallerg
patient
cours
trimethoprimsulfamethoxazol
also
may
consid
telithromycin
new
antibacteri
ketolid
low
propens
drug
resist
effect
firstlin
agent
limit
side
effect
list
pregnanc
categori
c
data
avail
regard
use
pregnanc
human
altern
regimen
bacteri
sinus
list
american
academi
otolaryngologyhead
neck
surgeri
guidelin
includ
fluoroquinolon
fluoroquinolon
recommend
pregnanc
avoid
possibl
bronchiti
inflamm
bronchial
mucou
membran
chronic
bronchiti
defin
product
cough
month
per
year
least
year
major
part
chronic
obstruct
pulmonari
diseas
rare
complic
pregnanc
acut
bronchiti
associ
cough
develop
upper
respiratori
tract
infect
usual
viral
origin
case
acut
bronchiti
caus
rhinoviru
influenza
adenoviru
caus
organ
includ
mycoplasma
pneumonia
c
pneumonia
cigarett
smoke
predomin
risk
factor
chronic
bronchiti
may
play
role
acut
diseas
acut
upper
respiratori
infect
cough
occasion
sputum
product
lowgrad
fever
may
present
dyspnea
uncommon
symptom
acut
bronchiti
antibiot
indic
rare
acut
diseas
although
prescrib
frequent
symptomat
relief
paramount
antibiot
use
reserv
suspect
bacteri
etiolog
women
respond
symptomat
relief
symptom
resolv
within
day
although
cough
may
persist
month
manag
chronic
bronchiti
outsid
scope
articl
rare
complic
pregnanc
pneumonia
influenza
combin
seventh
lead
caus
death
unit
state
number
one
caus
death
infecti
diseas
million
case
occur
annual
million
person
requir
hospit
death
per
popul
although
women
reproduct
age
much
lower
mortal
suscept
pneumonia
bacteri
viral
fungal
sourc
overal
pneumonia
primari
diagnosi
antepartum
admiss
nonobstetr
caus
although
pregnant
women
acquir
pneumonia
often
nonpregn
women
result
greater
morbid
mortal
physiolog
adapt
pregnanc
thu
pregnant
patient
requir
higher
level
surveil
intervent
studi
jin
colleagu
hospit
rate
communityacquir
pneumonia
pregnant
women
per
pregnanc
anoth
recent
report
note
preval
per
deliveri
communityacquir
pneumonia
organ
caus
bacteri
pneumonia
includ
streptococcu
pneumonia
h
influenza
c
pneumonia
mycoplasma
pneumonia
legionella
pneumophila
american
thorac
societi
note
even
extens
diagnost
test
etiolog
identifi
least
case
gram
stain
cultur
sputum
help
focus
therapi
use
controversi
bacteri
cultur
sputum
poor
sensit
specif
strain
identifi
streptococcu
pneumonia
common
although
overal
incid
decreas
women
reproduct
age
improv
use
pneumococc
conjug
vaccin
drugresist
strain
streptococcu
pneumonia
particularli
blactamaseresist
strain
increas
preval
mycoplasma
pneumonia
anoth
major
caus
bacteri
pneumonia
young
adult
outbreak
common
institutionaltyp
set
eg
colleg
persist
cough
common
diseas
rare
fatal
incid
c
pneumonia
pneumonia
unknown
although
common
schoolag
children
reinfect
throughout
life
common
occasion
present
pregnanc
risk
factor
pneumonia
includ
asthma
chronic
respiratori
diseas
hivaid
smoke
drug
use
sign
symptom
bacteri
pneumonia
pregnanc
nonpregn
individu
symptom
includ
cough
sputum
product
dyspnea
pleurit
chest
pain
sign
includ
fever
crackl
abnorm
breath
sound
chest
radiograph
perform
patient
aforement
find
pneumonia
suspect
chest
radiograph
confirm
pneumonia
rule
diagnos
suggest
possibl
caus
aid
determin
sever
ill
multilobar
pneumonia
consid
sever
process
singl
lobar
involv
gener
pregnant
women
pneumonia
hospit
observ
initi
therapi
workup
includ
complet
blood
count
electrolyt
assess
oxygen
blood
cultur
howev
blood
cultur
posit
time
matern
mortal
reduc
greatli
advent
antibiot
intraven
antibiot
therapi
start
empir
erythromycin
monotherapi
accept
initi
choic
treatment
consid
safe
pregnanc
treatment
success
rate
report
aspir
gramneg
organ
complic
note
box
suspect
identifi
cefotaxim
ceftriaxon
ad
erythromycin
regimen
endem
area
known
harbor
drugresist
streptococcu
pneumonia
cours
fluoroquinolon
may
requir
although
littl
inform
regard
possibl
human
teratogen
avail
abl
patient
clinic
respons
within
day
therapi
chang
first
hour
unless
mark
clinic
deterior
mani
differ
complic
bacteri
pneumonia
report
infect
site
occur
mening
arthriti
endocard
empyema
pericard
note
associ
pneumonia
sever
case
pneumonia
complic
sepsi
heart
failur
renal
failur
acut
respiratori
distress
syndrom
requir
intens
care
admiss
obstetr
complic
includ
fetal
distress
secondari
poor
oxygen
preterm
birth
munn
colleagu
found
women
pneumonia
significantli
like
deliv
week
preterm
birth
report
common
woman
pneumonia
underli
comorbid
condit
anemia
also
report
sever
studi
pneumonia
pregnanc
birth
weight
infant
born
women
antepartum
pneumonia
significantli
less
control
increas
number
pregnant
women
infect
hiv
pneumocysti
carinii
pneumonia
pcp
deserv
specif
mention
lead
caus
aidsrel
death
among
pregnant
women
unit
state
symptom
includ
dri
cough
dyspnea
tachypnea
diffus
infiltr
seen
chest
radiograph
ahmad
colleagu
report
case
pcp
pregnanc
mortal
extrem
high
fiftynin
percent
requir
mechan
ventil
number
may
inflat
none
patient
antiretrovir
therapi
diagnos
hiv
diagnos
pcp
treatment
trimethoprimsulfamethoxazol
pentamidin
hivinfect
patient
lymphocyt
count
less
histori
oropharyng
candidiasi
aidsdefin
ill
receiv
prophylaxi
prefer
prophylact
regimen
trimethoprimsulfamethoxazol
one
doublestrength
tablet
per
day
prophylaxi
effect
nonpregn
individu
expect
similarli
effect
pregnanc
viral
pneumonia
caus
commonli
influenza
varicellazost
viru
vzv
influenza
caus
two
rna
virus
famili
orthomyxovirida
influenza
influenza
b
histor
influenza
pregnant
women
associ
higher
rate
morbid
mortal
cours
influenza
pregnanc
report
first
epidem
case
pregnant
women
influenzalik
ill
evalu
pneumonia
complic
case
patient
pregnanc
interrupt
matern
death
mortal
highest
last
month
pregnanc
increas
complic
pneumonia
influenza
epidem
pregnant
women
new
york
citi
die
complic
flu
pregnant
women
account
nearli
half
death
women
childbear
age
epidem
pregnant
women
die
minnesota
death
attribut
respiratori
insuffici
secondari
pulmonari
edema
pneumonia
mullooli
colleagu
review
influenza
complic
pregnanc
four
epidem
period
pregnant
women
sought
outpati
medic
attent
acut
respiratori
diseas
influenza
season
significantli
often
nonpregn
women
influenza
infect
epidem
winter
month
spread
aerosol
droplet
particl
creat
person
cough
sneez
speak
particl
filter
recipi
nose
pharynx
reach
alveoli
clinic
present
influenza
seem
alter
pregnanc
incub
period
influenza
day
averag
day
gener
patient
infecti
day
onset
symptom
day
thereaft
young
children
immunocompromis
adult
shed
viru
much
longer
period
time
infant
infect
hospit
shed
viru
day
symptom
influenza
includ
cough
fever
malais
rhiniti
myalgia
headach
chill
sore
throat
less
common
symptom
includ
nausea
vomit
otiti
conjunctiv
burn
sign
influenza
includ
fever
tachycardia
facial
flush
clear
nasal
discharg
cervic
adenopathi
adult
fever
gener
last
day
resolut
symptom
normal
within
week
cough
malais
may
persist
longer
week
pneumonia
either
viral
superimpos
bacteri
wellrecogn
complic
influenza
initi
patient
present
respiratori
distress
case
viral
pneumonia
chest
radiograph
diffus
bilater
infiltr
seen
sign
pneumonia
includ
cours
rale
rhonchi
wheez
dyspnea
tachypnea
typic
superimpos
bacteri
pneumonia
occur
day
symptom
influenza
resolv
local
consolid
seen
chest
radiograph
superimpos
bacteri
pneumonia
pregnant
women
influenza
pneumonia
evalu
may
treat
one
antivir
agent
approv
treatment
influenza
adamantin
ionchannel
inhibitor
includ
amantadin
rimantadin
activ
influenza
may
given
within
first
hour
symptom
reduc
symptom
durat
minim
drug
resist
therapi
discontinu
within
hour
symptom
resolv
within
day
neuraminidas
inhibitor
effect
treatment
influenza
b
oseltamivir
given
oral
approv
treatment
chemoprophylaxi
zanamivir
inhal
medic
approv
treatment
sever
report
bronchospasm
patient
asthma
took
drug
shorten
durat
symptom
averag
day
limit
data
safeti
pregnanc
four
drug
us
food
drug
administr
categori
c
therefor
use
benefit
outweigh
risk
vzv
dna
viru
affect
per
pregnanc
pneumonia
common
complic
adult
occur
case
avail
antivir
therapi
mortal
pregnant
women
vzv
pneumonia
high
mortal
era
antivir
therapi
approxim
risk
factor
varicella
pneumonia
includ
smoke
presenc
skin
lesion
pulmonari
symptom
begin
day
onset
rash
fever
symptom
includ
cough
hemoptysi
dyspnea
tachypnea
pleurit
chest
pain
chest
radiograph
show
diffus
miliari
nodular
infiltr
treatment
intraven
acyclovir
although
valu
proven
rigor
scientif
studi
varicella
pneumonia
associ
preterm
labor
studi
although
recent
report
substanti
varicellazost
immunoglobulin
given
within
hour
exposur
varicella
attenu
prevent
infect
suscept
individu
contraind
pregnanc
varicella
vaccin
contraind
pregnanc
liveattenu
vaccin
sever
acut
respiratori
syndrom
sar
caus
novel
coronaviru
sinc
atyp
pneumonia
affect
peopl
result
death
worldwid
transmiss
respiratori
droplet
close
person
contact
viru
live
urin
stool
day
symptom
pregnant
nonpregn
women
includ
fever
chill
rigor
malais
myalgia
patient
infecti
second
week
ill
often
chest
radiograph
find
gener
patchi
interstiti
infiltr
patient
note
lymphopenia
well
thrombocytopenia
diagnosi
made
cultur
polymeras
chain
reaction
elisa
immunofluoresc
assay
guidelin
protocol
diagnost
test
avail
world
health
organ
web
site
complic
sar
pneumonia
includ
respiratori
failur
superimpos
bacteri
infect
dissemin
intravascular
coagul
largest
case
seri
pregnant
women
sar
report
wong
colleagu
china
twelv
pregnant
women
infect
sar
februari
juli
high
rate
morbid
mortal
note
case
fatal
rate
larg
portion
case
complic
firsttrimest
spontan
abort
preterm
birth
intrauterin
growth
restrict
case
vertic
transmiss
report
treatment
includ
broadspectrum
antibiot
cover
superimpos
bacteri
infect
highdos
steroid
possibl
ribavirin
ribavirin
shown
teratogen
effect
anim
use
pregnanc
establish
fungal
pneumonia
usual
seen
women
immunocompromis
eg
hiv
infect
histoplasmosi
blastomycosi
common
fungal
pneumonia
complic
pregnanc
usual
mild
selflimit
cryptococcosi
also
may
present
pregnanc
although
mening
common
pneumonia
coccidioidomycosi
also
may
caus
pneumonia
pregnanc
associ
erythema
nodosum
occur
frequent
endem
area
fungal
pneumonia
present
similarli
bacteri
viral
pneumonia
cough
dyspnea
fever
chest
pain
common
complaint
pregnant
women
complic
fungal
infect
includ
dissemin
diseas
treat
amphotericin
b
ketoconazol
although
safeti
data
longterm
use
pregnanc
limit
regardless
type
pneumonia
import
aggress
monitor
treatment
sake
mother
fetu
oxygen
supplement
provid
prevent
fetal
acidemia
broadspectrum
empir
antibiot
start
identif
etiolog
agent
antibiot
therapi
tailor
specif
organ
laboratori
test
return
given
pregnant
women
young
healthi
intens
earli
treatment
like
result
good
outcom
tuberculosi
pulmonari
infect
caus
acidfast
bacillu
mycobacterium
tuberculosi
although
mycobacterium
bovi
africanum
microti
caus
human
diseas
tuberculosi
encount
commonli
estim
eight
nine
million
new
case
tuberculosi
occur
worldwid
half
occur
asia
case
tuberculosi
unit
state
report
center
diseas
control
prevent
per
repres
decreas
case
occur
foreignborn
person
sever
factor
implic
resurg
tuberculosi
unit
state
occur
late
earli
includ
increas
immigr
countri
high
preval
tuberculosi
hiv
infect
emerg
resist
strain
poverti
homeless
drug
abus
declin
tuberculosisrel
health
servic
increas
accompani
increas
frequenc
tuberculosi
pregnant
women
appropri
therapi
pregnanc
affect
cours
tuberculosi
advers
howev
tuberculosi
may
affect
pregnanc
outcom
advers
low
birth
weight
preterm
deliveri
increas
perinat
mortal
rate
report
set
incomplet
treatment
advanc
extrapulmonari
tuberculosi
transmiss
infect
pregnanc
believ
nonpregn
women
mycobacterium
tuberculosi
transmit
commonli
person
person
respiratori
droplet
aerosol
cough
sneez
sing
speak
droplet
dri
rapidli
may
remain
suspend
air
sever
hour
factor
associ
likelihood
transmiss
includ
intimaci
durat
contact
degre
infecti
case
share
environ
contact
patient
sputum
smearnegativecultureposit
tuberculosi
less
infecti
cultureneg
pulmonari
diseas
extrapulmonari
tuberculosi
noninfecti
droplet
gain
direct
access
termin
air
passag
inhal
approxim
reach
alveoli
activ
alveolar
macrophag
ingest
bacilli
bacilli
multipli
growth
quickli
kill
macrophag
lyse
usual
initi
stage
infect
asymptomat
two
week
infect
two
addit
host
respons
developa
tissuedamag
respons
macrophageactiv
respons
larg
number
activ
macrophag
accumul
site
primari
lesion
granulomat
lesion
form
lesion
consist
lymphocyt
activ
macrophag
macrophag
contain
bacilli
travel
lymph
node
rest
bodi
mani
patient
infect
mycobacterium
tuberculosi
activ
form
diseas
patient
go
activ
diseas
macrophageactiv
respons
weak
therefor
mycobacteri
growth
inhibit
intensifi
tissuedamag
respons
surround
tissu
damag
progress
lesion
enlarg
infect
individu
develop
activ
diseas
within
year
infect
clinic
ill
shortli
infect
term
primari
tuberculosi
dormant
bacilli
may
persist
year
becom
reactiv
refer
secondari
postprimari
tuberculosi
estim
approxim
infect
person
eventu
develop
activ
tuberculosi
group
risk
infect
progress
activ
diseas
list
box
factor
place
patient
high
risk
develop
activ
diseas
includ
age
hiv
coinfect
suppress
cellular
immun
silicosi
malign
neoplasm
hemophilia
chronic
renal
failur
insulindepend
diabet
mellitu
among
infect
person
incid
tuberculosi
highest
late
adolesc
earli
adulthood
incid
among
women
peak
year
age
clinic
manifest
tuberculosi
usual
includ
fever
night
sweat
cough
weight
loss
anorexia
gener
malais
weak
massiv
hemoptysi
occur
result
eros
pulmonari
vessel
wall
tuberculin
caviti
find
includ
wast
rale
rhonchi
club
finger
hypoxia
chest
radiograph
classic
find
upper
lobe
infiltr
caviti
howev
film
may
normal
find
nodul
diffus
infiltr
cavit
mediastin
lymphadenopathi
also
may
seen
although
organ
system
affect
extrapulmonari
site
involv
commonli
tuberculosi
includ
lymph
node
pleura
genitourinari
tract
bone
joint
mening
peritoneum
extrapulmonari
tuberculosi
seen
often
hiv
coinfect
five
percent
pregnant
women
tuberculosi
extrapulmonari
diseas
miliari
tuberculosi
due
hematogen
spread
bacilli
may
occur
recent
infect
reactiv
old
dissemin
foci
common
symptom
includ
weak
fever
weight
loss
miliari
tuberculosi
difficult
diagnosi
make
may
radiograph
find
present
radiolog
find
may
includ
larg
infiltr
interstiti
infiltr
pleural
effus
sputum
smear
acidfast
bacilli
neg
case
hematolog
abnorm
seen
miliari
tuberculosi
includ
anemia
leukopenia
neutrophil
leukocytosi
polycythemia
dissemi
congenit
tuberculosi
rare
often
fatal
diseas
usual
acquir
way
hematogen
spread
fetu
placenta
umbil
cord
bacilli
retriev
decidua
amnion
chorion
villi
fetu
also
may
becom
infect
mycobacterium
tuberculosi
ingest
amniot
fluid
hematogen
acquisit
commonli
result
granulomat
complex
within
liver
acquisit
way
aspir
result
often
complex
lung
gastrointestin
tract
beitzk
detail
criteria
congenit
tuberculosi
firm
diagnosi
tuberculosi
newborn
primari
complex
newborn
liver
primari
complex
identifi
liver
tubercul
lesion
must
document
first
day
life
exclud
extrauterin
infect
mani
case
newborn
diagnos
mother
hageman
colleagu
review
case
congenit
tuberculosi
common
sign
symptom
descend
order
respiratori
distress
fever
liverspleen
enlarg
poor
feed
lethargi
lymphadenopathi
review
neonat
mortal
howev
three
quarter
death
treatment
diagnosi
made
post
mortem
initi
tuberculin
test
may
neg
may
remain
sever
month
neonat
tuberculosi
far
common
occur
newborn
infect
exposur
infect
mother
famili
member
current
guidelin
screen
tuberculosi
includ
skin
test
women
highrisk
group
box
ppd
tuberculin
skin
test
test
detect
mycobacterium
tuberculosi
infect
reliabl
asymptomat
person
test
becom
posit
week
infect
sensit
lymphocyt
travel
site
prolifer
produc
cytokin
consequ
rais
erythemat
area
form
size
reactiv
area
determin
whether
test
posit
size
reactiv
area
use
defin
posit
test
vari
risk
factor
indur
least
mm
use
patient
hiv
infect
recent
contact
person
activ
tuberculosi
organ
transplant
fibrot
chang
chest
radiograph
consist
old
tuberculosi
indur
least
mm
use
patient
recent
immigr
within
year
high
preval
countri
intraven
drug
user
resid
employe
highrisk
set
eg
jail
nurs
home
shelter
hospit
condit
associ
high
risk
diseas
infect
indur
least
mm
use
lowrisk
peopl
test
low
sensit
specif
case
activ
tuberculosi
addit
fals
neg
result
common
immunocompromis
patient
patient
receiv
bacil
vaccin
falseposit
test
although
skin
indur
rare
exce
mm
fals
posit
result
pregnant
women
posit
test
undergo
chest
radiograph
abdomin
shield
assess
evid
diseas
hematolog
find
includ
anemia
leukocytosi
occasion
hyponatremia
patient
suspect
activ
pulmonari
tuberculosi
three
sputum
specimenscollect
earli
morningshould
taken
acid
fast
bacillu
afb
smear
mycobacteriolog
cultur
tissu
obtain
cultur
import
put
formaldehyd
compromis
test
accuraci
definit
diagnosi
depend
isol
identif
mycobacterium
tuberculosi
diagnost
specimen
sputum
tissu
cultur
timeconsum
process
mycobacterium
tuberculosi
take
week
grow
howev
import
drug
suscept
determin
treatment
optim
individu
patient
treatment
tuberculosi
pregnanc
vari
depend
diseas
statu
ie
ppd
posit
alon
versu
activ
diseas
drug
resist
test
endem
area
pregnant
woman
posit
ppd
indic
infect
evid
activ
diseas
treatment
isoniazid
inh
may
withheld
deliveri
increas
risk
hepatotox
pregnant
women
infect
hiv
start
therapi
immedi
annual
risk
progress
activ
diseas
pregnant
women
risk
factor
progress
includ
known
recent
skintest
convertor
also
delay
initi
therapi
manag
activ
pulmonari
tuberculosi
pregnanc
similar
nonpregn
women
inh
rifampin
ethambutol
emb
use
initi
treatment
regimen
local
preval
isol
resist
inh
high
pyrazinamid
ad
regimen
result
suscept
test
avail
medic
cross
placenta
shown
teratogen
effect
women
treat
breastfe
although
medic
found
breast
milk
amount
drug
reach
therapeut
level
suffici
treatment
newborn
pregnant
postpartum
women
receiv
pyridoxin
tabl
list
medic
use
treatment
tuberculosi
inh
dose
daili
two
three
time
per
week
side
effect
includ
aminotransferas
elev
hepat
peripher
neurotox
lupuslik
syndrom
hepat
seem
common
pregnant
patient
take
inh
thu
liver
enzym
evalu
frequent
pyridoxin
administ
dose
pyridoxin
prenat
vitamin
vari
gener
dose
inadequ
purpos
rifampin
also
firstlin
agent
dose
daili
two
three
time
per
week
side
effect
includ
rash
nauseavomit
hepat
patient
must
warn
rifampin
turn
urin
sweat
sputum
tear
orang
emb
firstlin
drug
treat
form
tuberculosi
includ
initi
treatment
regimen
primarili
prevent
emerg
rifampin
resist
primari
resist
inh
may
present
advers
effect
includ
retrobulbar
neuriti
peripher
neuriti
rare
skin
reaction
requir
discontinu
drug
emb
consid
safe
use
pregnanc
pyrazinamid
firstlin
agent
highli
activ
dormant
semidorm
bacteri
popul
hepatotox
attribut
standard
dose
pyrazinamid
pza
occur
approxim
case
mild
anorexia
nausea
common
transient
morbilliform
rash
also
occur
usual
selflimit
littl
inform
safeti
pza
pregnanc
benefit
pza
may
outweigh
possibl
risk
area
drugresist
tuberculosi
endem
streptomycin
avoid
pregnanc
increas
risk
congenit
deaf
